Mebazaa, A., Davison, B., Chioncel, O., Cohen-Solal, A., Diaz, R., Filippatos, G., . . . Cotter, G. (2022). Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. The Lancet (British edition), 400(10367), 1938-1952. https://doi.org/10.1016/S0140-6736(22)02076-1
Chicago-Zitierstil (17. Ausg.)Mebazaa, Alexandre, et al. "Safety, Tolerability and Efficacy of Up-titration of Guideline-directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-label, Randomised, Trial." The Lancet (British Edition) 400, no. 10367 (2022): 1938-1952. https://doi.org/10.1016/S0140-6736(22)02076-1.
MLA-Zitierstil (9. Ausg.)Mebazaa, Alexandre, et al. "Safety, Tolerability and Efficacy of Up-titration of Guideline-directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-label, Randomised, Trial." The Lancet (British Edition), vol. 400, no. 10367, 2022, pp. 1938-1952, https://doi.org/10.1016/S0140-6736(22)02076-1.